Literature DB >> 19525119

Preoperative radiochemotherapy in the treatment of advanced oral cancer: outcome of 276 patients.

Clemens Klug1, Dominik Berzaczy, Martin Voracek, Christina Nell, Oliver Ploder, Werner Millesi, Rolf Ewers.   

Abstract

INTRODUCTION: The aim of this study was to review survival and locoregional control in patients with advanced oral and oropharyngeal squamous cell carcinoma treated by multimodal therapy with preoperative radiochemotherapy and radical surgery. MATERIAL: Retrospective cohort study.
METHODS: Included in this analysis are 276 consecutive patients with UICC disease stages III and IV (T2: 13.0%; T3: 16.7%; T4: 70.3%; N0: 29.7%; N1: 20.3%; N2: 45.3%; N3: 4.7%; stage III: 16.3%; stage IV: 83.7%). All patients received preoperative radiochemotherapy (50Gy, Mitomycin and 5-Fluorouracil) and radical locoregional resection.
RESULTS: Median surveillance period was 101.4 months (24-202 months). 5-year overall survival probability was 53.9%. 5-year local control probability was 70.2%.
CONCLUSION: These results underline the reliability of preoperative treatment of patients with oral and oropharyngeal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19525119     DOI: 10.1016/j.jcms.2008.11.012

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  6 in total

1.  Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy.

Authors:  Matthias Kreppel; Uta Drebber; Hans-Theodor Eich; Timo Dreiseidler; Joachim E Zöller; Rolf-Peter Müller; Martin Scheer
Journal:  Strahlenther Onkol       Date:  2011-03-14       Impact factor: 3.621

2.  Neoadjuvant radiotherapy of head and neck carcinoma: an obstacle for plastic reconstruction?

Authors:  Stefan Riml; Franz Böhler; Lorenz Larcher; Alexander de Vries; Wolfgang Elsässer; Peter Kompatscher
Journal:  Wien Klin Wochenschr       Date:  2012-08-01       Impact factor: 1.704

3.  Neoadjuvant chemoradiation in squamous cell carcinoma of the maxillary sinus: a 26-year experience.

Authors:  Matthias Kreppel; Sarah Danscheid; Martin Scheer; Jan Christoffer Lüers; Hans Theodor Eich; Joachim E Zöller; Orlando Guntinas-Lichius; Dirk Beutner
Journal:  Chemother Res Pract       Date:  2012-09-29

4.  Outcome of Neoadjuvant Chemotherapy on Local Recurrence and Distant Metastasis of Oral Squamous Cell Carcinoma: A Retrospective Study.

Authors:  Reza Tabrizi; Ata Garajei; Ehsan Shafie; Samira Jamshidi
Journal:  J Dent (Shiraz)       Date:  2016-09

5.  Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial.

Authors:  Jens von der Grün; Ria Winkelmann; Iris Burck; Daniel Martin; Franz Rödel; Peter Johannes Wild; Katrin Bankov; Andreas Weigert; Ivan-Maximiliano Kur; Christian Brandts; Natalie Filmann; Christian Issing; Philipp Thönissen; Anna Maria Tanneberger; Claus Rödel; Shahram Ghanaati; Panagiotis Balermpas
Journal:  Front Oncol       Date:  2022-03-24       Impact factor: 6.244

6.  Experience in Intra-arterial Chemotherapy using Two Protocols for the Treatment of OSCC over Two Decades at the University Hospital Vienna.

Authors:  Christina Eder-Czembirek; Sascha Rechinger; Gabriela Kornek; Edgar Selzer; Rudolf Seemann
Journal:  Clinics (Sao Paulo)       Date:  2018-10-18       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.